Apoptotic cell death in disease—Current understanding of the NCCD 2023

I Vitale, F Pietrocola, E Guilbaud… - Cell Death & …, 2023 - nature.com
Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase
family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis …

Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins

R Singh, A Letai, K Sarosiek - Nature reviews Molecular cell biology, 2019 - nature.com
The loss of vital cells within healthy tissues contributes to the development, progression and
treatment outcomes of many human disorders, including neurological and infectious …

Immunogenic cell death and DAMPs in cancer therapy

DV Krysko, AD Garg, A Kaczmarek, O Krysko… - Nature reviews …, 2012 - nature.com
Although it was thought that apoptotic cells, when rapidly phagocytosed, underwent a silent
death that did not trigger an immune response, in recent years a new concept of …

[HTML][HTML] Autophagy and apoptosis dysfunction in neurodegenerative disorders

S Ghavami, S Shojaei, B Yeganeh, SR Ande… - Progress in …, 2014 - Elsevier
Autophagy and apoptosis are basic physiologic processes contributing to the maintenance
of cellular homeostasis. Autophagy encompasses pathways that target long-lived cytosolic …

Multiple functions of BCL-2 family proteins

JM Hardwick, L Soane - Cold Spring Harbor …, 2013 - cshperspectives.cshlp.org
BCL-2 family proteins are the regulators of apoptosis, but also have other functions. This
family of interacting partners includes inhibitors and inducers of cell death. Together they …

Quiescent Sox2+ cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma

RJ Vanner, M Remke, M Gallo, HJ Selvadurai… - Cancer cell, 2014 - cell.com
Functional heterogeneity within tumors presents a significant therapeutic challenge. Here
we show that quiescent, therapy-resistant Sox2+ cells propagate sonic hedgehog subgroup …

scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy

JK Ocasio, B Babcock, D Malawsky, SJ Weir… - Nature …, 2019 - nature.com
Targeting oncogenic pathways holds promise for brain tumor treatment, but inhibition of
Sonic Hedgehog (SHH) signaling has failed in SHH-driven medulloblastoma. Cellular …

[HTML][HTML] The role of Bcl-2 proteins in modulating neuronal Ca2+ signaling in health and in Alzheimer's disease

M Callens, N Kraskovskaya, K Derevtsova… - … et Biophysica Acta (BBA …, 2021 - Elsevier
The family of B-cell lymphoma-2 (Bcl-2) proteins exerts key functions in cellular health. Bcl-2
primarily acts in mitochondria where it controls the initiation of apoptosis. However, during …

[HTML][HTML] Poly (2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and …

D Hwang, T Dismuke, A Tikunov, EP Rosen… - … , Biology and Medicine, 2021 - Elsevier
We report a nanoparticle formulation of the SHH-pathway inhibitor vismodegib that improves
efficacy for medulloblastoma, while reducing toxicity. Limited blood–brain barrier (BBB) …

Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastoma

TR Gershon, AJ Crowther, A Tikunov, I Garcia… - Cancer & …, 2013 - Springer
Background While aerobic glycolysis is linked to unconstrained proliferation in cancer, less
is known about its physiological role. Why this metabolic program that promotes tumor …